DigestRedComo funciona
Red
/
Empresas
Ev
No verificado

Evaxion Biotech

Sobre qué escribimos

Anuncios brevesBiotecnologíaFinanzasMedicina Salud BienestarPublicidad/Marketing/Medios de comunicación/Comunicación

31 Comunicados de prensa

Ver todos los comunicados de prensa
01/07/2025
Biotecnología
Anuncios breves
Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
25/06/2025
Biotecnología
Anuncios breves
Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
03/06/2025
Biotecnología
Anuncios breves
Evaxion receives grant funding to design new polio vaccine
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
27/05/2025
Biotecnología
Anuncios breves
Evaxion announces business update and first quarter 2025 financial results
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
23/05/2025
Biotecnología
Anuncios breves
Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
22/05/2025
Biotecnología
Anuncios breves
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
28/04/2025
Biotecnología
Anuncios breves
80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
10/04/2025
Biotecnología
Anuncios breves
Evaxion to present at World Vaccine Congress
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
01/04/2025
Biotecnología
Finanzas
Anuncios breves
Evaxion announces business update and full year 2024 financial results
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0
27/03/2025
Biotecnología
Anuncios breves
Evaxion to announce business update and full year 2024 financial results on April 1, 2025
Fuente
Evaxion Biotech
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0